Company Number: 13252683

Analysis Date: 2025-07-29 18:01 UTC

Comprehensive Financial Health Assessment for Life Science Works Ltd.

---

1. Financial Health Score: A-

Explanation:
Life Science Works Ltd. demonstrates strong financial "vital signs" typical of a growing and well-managed small private limited company. The company shows a robust increase in net current assets and shareholders' funds over recent years, healthy cash reserves, and a solid equity base. Minor caution relates to relatively low fixed assets compared to total assets, typical for a consultancy business, and the absence of an income statement (due to abridged filing exemptions) limits full profitability insights. Overall, the financial "pulse" is strong, suggesting sound financial health.

---

2. Key Vital Signs

Metric	2025 (£)	Interpretation
Cash at Bank	249,697	Very healthy cash flow; strong liquidity ensures ability to meet short-term obligations ("healthy heartbeat").
Current Assets	250,753	High liquidity; most assets are cash, reflecting minimal inventory or receivables risk.
Current Liabilities	39,079	Manageable short-term debts; low risk of liquidity distress.
Net Current Assets (Working Capital)	211,674	Strong working capital indicates excellent short-term financial stability.
Fixed Assets	16,142	Relatively low but appropriate for consultancy; no signs of over-investment in illiquid assets.
Total Assets less Current Liabilities	227,816	Reflects strong net asset position; a positive "balance sheet health" indicator.
Shareholders' Funds (Equity)	227,816	Growing equity base (up from £13,946 in 2021) shows retained earnings accumulation; no signs of shareholder distress.
Share Capital	2.00	Nominal; typical for small private companies; minimal external shareholder dilution.
Debtors	1,056	Very low receivables; indicates efficient cash collection or low credit sales.

Additional Observations:

• The company employs two directors and maintains a small workforce (average 2 employees), consistent with a focused consultancy service.
• The company is active, not in liquidation or administration, and filings are timely and up to date, indicating good compliance health.

---

3. Diagnosis: Financial Condition and Business Health

Life Science Works Ltd. exhibits the "vital signs" of a financially healthy and stable small private company operating in the management consultancy sector. The company's cash reserves are strong, providing a "healthy pulse" to cover liabilities and unforeseen expenses without stress. The significant growth in equity and net assets over four years suggests the business is retaining profits and growing sustainably.

Low debtor balances and high cash indicate efficient operations and good credit control, which are "symptoms of financial wellness." The lack of significant fixed asset investment is typical for a consultancy, where intellectual capital rather than physical assets drives value.

There are no symptoms of financial distress such as overdue filings, excessive liabilities, or shrinking equity. The company's structure and financial profile suggest it is in a stable and growing phase, with good governance reflected in timely reporting and director appointments.

---

4. Recommendations: Actions to Maintain and Improve Financial Wellness

• Maintain Strong Cash Management: Continue to monitor cash flow closely to preserve liquidity, ensuring the company can respond flexibly to market opportunities or challenges.
• Profit & Loss Transparency: Although abridged accounts are permitted, consider preparing internal detailed profit and loss statements to monitor operational profitability and margin trends for better strategic decision-making.
• Investment in Growth: Evaluate opportunities for strategic investment, whether in intellectual property, marketing, or technology, to support business expansion, leveraging the strong equity base.
• Risk Management: Regularly review credit risk policies and current liabilities to guard against any sudden market or client payment risks, despite current low debtor levels.
• Governance and Compliance: Continue timely filings and maintain robust corporate governance to avoid penalties and maintain stakeholder confidence.
• Succession and Control Planning: Given that a key director holds significant control, consider succession planning to mitigate risks associated with key-person dependency.

---